AxoGen Inc. closed its public offering of common shares with net proceeds of about $132.5 million.
The company offered 3,450,000 shares at $41 apiece, and the underwriters fully exercised their overallotment option to buy 450,000 additional shares.
AxoGen intends to use the net proceeds for long-term facility and capacity expansion and general corporate purposes.
Jefferies LLC and Leerink Partners LLC acted as joint book-running managers, while William Blair & Co. LLC and JMP Securities LLC acted as co-managers for the offering.
Alachua, Fla.-based AxoGen develops and markets surgical solutions for peripheral nerve injuries.
